Abstract
Orthotopic liver transplantation (OLT) offers the best chance for cure in the setting of unresectable hepatocellular carcinoma (HCC). A consensus statement recommends locoregional therapy (LRT) be considered in patients with HCC who are expected to wait more than 6 months for OLT to diminish dropout from the waiting list because of tumor progression. This article reviews LRT as a bridge to OLT in patients with HCC. © JNCCN - Journal of the National Comprehensive Cancer Network.
Cite
CITATION STYLE
Prasad, M. A., & Kulik, L. M. (2014, August 1). The role of bridge therapy prior to orthotopic liver transplantation. JNCCN Journal of the National Comprehensive Cancer Network. Harborside Press. https://doi.org/10.6004/jnccn.2014.0113
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.